Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E N Jansen

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
European Neurology|January 1, 1990
Familial, alternating Bell's palsy with dominant inheritanceG Hageman, P F Ippel, E N Jansen, et al.
Clinical Neurology and Neurosurgery|January 1, 1992
Clinical efficacy of Sinemet CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open, and a double-blind, double-dummy, multicenter treatment evaluation. The Dutch Sinemet CR Study GroupE C Wolters, M W Horstink, R A Roos, et al.
Advances in Neurology|January 1, 1993
Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study GroupE C Wolters, M W Horstink, R A Roos, et al.
Acta Neurologica Scandinavica|March 28, 1998
Primary cerebellar nocardiosis and alveolar proteinosisW G Oerlemans, E N Jansen, R L Prevo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1995
Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositoriesT van Laar, E N Jansen, C Neef, et al.
Neuroscience Letters|June 3, 1999
Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphismM A Bon, E N Jansen Steur, R A de Vos, et al.
Neurobiology of Aging|June 27, 2000
Are Alzheimer's disease, hypertension, and cerebrocapillary damage related?E Farkas, R A De Vos, E N Jansen Steur, et al.
Neurology|October 1, 1996
Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's diseaseE C Wolters, E N Jansen, H G Tuynman-Qua, et al.
Progress in Brain Research|February 5, 1999
Neuropathological hallmarks of Alzheimer's and Parkinson's diseasesH Braak, R A de Vos, E N Jansen, et al.
Acta Neuropathologica|September 29, 1999
Mossy fiber involvement in progressive supranuclear palsyK Arai, E Braak, R A de Vos, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
European Neurology|January 1, 1990
Familial, alternating Bell's palsy with dominant inheritanceG Hageman, P F Ippel, E N Jansen, et al.
Clinical Neurology and Neurosurgery|January 1, 1992
Clinical efficacy of Sinemet CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open, and a double-blind, double-dummy, multicenter treatment evaluation. The Dutch Sinemet CR Study GroupE C Wolters, M W Horstink, R A Roos, et al.
Advances in Neurology|January 1, 1993
Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study GroupE C Wolters, M W Horstink, R A Roos, et al.
Acta Neurologica Scandinavica|March 28, 1998
Primary cerebellar nocardiosis and alveolar proteinosisW G Oerlemans, E N Jansen, R L Prevo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1995
Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositoriesT van Laar, E N Jansen, C Neef, et al.
Neuroscience Letters|June 3, 1999
Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphismM A Bon, E N Jansen Steur, R A de Vos, et al.
Neurobiology of Aging|June 27, 2000
Are Alzheimer's disease, hypertension, and cerebrocapillary damage related?E Farkas, R A De Vos, E N Jansen Steur, et al.
Neurology|October 1, 1996
Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's diseaseE C Wolters, E N Jansen, H G Tuynman-Qua, et al.
Progress in Brain Research|February 5, 1999
Neuropathological hallmarks of Alzheimer's and Parkinson's diseasesH Braak, R A de Vos, E N Jansen, et al.
Acta Neuropathologica|September 29, 1999
Mossy fiber involvement in progressive supranuclear palsyK Arai, E Braak, R A de Vos, et al.
Pageof 7